查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829929

2025年急性護理症候群檢測全球市場報告

Acute Care Syndromic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，急性護理症候群檢測市場快速擴張，市場規模從2024年的40.8億美元成長至2025年的45.9億美元，複合年成長率達12.3%。這段時期的成長可歸因於人們對抗生素抗藥性認知的不斷提高、政府對感染疾病的投入增加、醫療基礎設施投資的增加、對症候群檢測的重視程度不斷提高、遠端醫療的擴展以及感染疾病的增加。

預計未來幾年急性照護症候群檢測市場將快速成長，到2029年將達到73.9億美元，複合年成長率為12.7%。預測期內的成長動力包括感染疾病流行、快速診斷解決方案需求的不斷成長、醫療保健服務的不斷擴展、多重症候群檢測組合的使用日益增多以及老年人口的成長。預測期內的主要趨勢包括向就地檢驗的轉變、雲端基礎平台的整合、多重症候群檢測組合的採用、人工智慧工具的開發以及症候群檢測的自動化。

急性護理綜合症檢測是一種快速的分子診斷方法，可同時檢測單一患者樣本中的多種病原體。此方法主要用於急診和緊急醫療監護，能夠快速診斷感染疾病，從而加快治療決策，改善患者預後，並縮短住院時間。

急性照護症候群檢測市場的主要疾病類型包括呼吸系統疾病、胃腸道疾病、泌尿生殖系統疾病和熱帶疾病。呼吸系統疾病會影響肺部、呼吸道和呼吸道，引起咳嗽、呼吸急促和發燒等症狀。用於檢測的樣本類型包括血液、尿液、體液、糞便和拭子。檢測針對細菌、病毒、真菌和寄生蟲，廣泛應用於醫院、臨床和診斷實驗室、研究和學術機構以及其他醫療機構。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供急性護理症候群檢測市場統計數據，例如全球市場規模、區域佔有率、急性護理症候群檢測市場中的競爭對手、詳細的急性護理症候群檢測細分市場、市場趨勢和機遇，以及在急性護理症候群檢測行業取得成功所需的數據。本急性護理綜合症檢測市場研究報告對該行業的現狀和未來情況進行了詳細分析，為您提供所需的全面展望。

未來五年的預測成長率為12.7%，較我們先前對該市場的預測略有下降0.2%。下降的主要原因是美國與其他國家之間的關稅影響。這種影響可能會直接影響美國，導致新加坡的多重聚合酵素鏈鎖反應(PCR) 試劑盒和韓國的自動化樣本製備模組供應中斷，從而減緩感染疾病診斷的速度。由於互惠關稅以及貿易緊張局勢和限制措施不斷升級對全球經濟和貿易的負面影響，這種影響也將更加廣泛。

感染疾病的日益流行預計將推動急性護理症候群檢測市場的成長。感染疾病是由細菌、病毒、真菌和寄生蟲等有害微生物引起的，可透過人類與人類、動物和環境傳播。人口成長、都市化、全球旅行、抗菌素抗藥性和氣候變遷等因素導致這些疾病的發病率上升，推動了對有效診斷和治療解決方案的需求。急性護理綜合症檢測在透過多重分子診斷識別病原體和合併感染以及確定有針對性的治療方面發揮關鍵作用。例如，2024 年 2 月，英國衛生安全局報告稱，2024 年第 4 週的流感陽性率從前一周的 14.0% 上升至 16.6%。流感樣疾病（ILI）就診率也上升，達到每10萬人9.8例（前一周為7.5例），流感相關住院人數也上升至每10萬人7.63例（前一周為5.12例）。受此影響，感染疾病發生率的上升正刺激急性護理症候群檢測市場的擴張。

急性護理綜合症檢測市場的主要企業正在利用多重即時聚合酵素鏈鎖反應(PCR) 技術的進步來提高診斷準確性、快速檢測病原體、簡化實驗室工作流程並縮短週轉時間。多重即時PCR是一種先進的分子診斷方法，可在單一反應中同時檢測和量化多種病原體或基因標靶，從而提高疾病診斷的效率和準確性。 2023 年 4 月，荷蘭生物技術公司 QIAGEN NV 在日本推出了 QIAstat-Dx 症候群檢測解決方案。本系統採用 SARS-CoV-2 呼吸道面板，可從單一檢體中檢測出 20 多種病原體。使用多重即時PCR技術，與傳統的 PCR 檢測相比，它可以以最少的努力快速提供結果。截至 2022 年底，全球已安裝超過 3,500 套 QIAstat-Dx 系統，協助診斷呼吸道、胃腸道和腦膜炎相關疾病。該系統已在 100 多個國家投入使用，提高了全球範圍內症候群檢測的可及性。

2023年5月，美國生技公司Applied Biocode與Medline Industries LP達成合作，擴大Biocode MDx-3000系統的銷售。 Medline Industries LP是一家專注於醫療用品和醫療保健服務的美國醫療保健公司，將支援Applied Biocode多重診斷解決方案的銷售，進一步增強其綜合檢測能力。

急性照護症候群檢測市場由提供全面病原體檢測、快速週轉時間和抗菌藥物管理支援等服務的營業單位所獲得的收益構成。市場價值還包括服務提供者銷售或包含在其服務產品中的相關產品的價值。急性護理綜合症檢測市場還包括採血管和尿液容器、PCR 和 RT-PCR 儀器以及讀取設備的銷售。該市場的價值為“出廠價”，即產品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的產品價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球急性照護症候群檢查：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球急性護理綜合症檢測市場：成長率分析
  • 全球急性照護症候群檢測市場表現：規模與成長，2019-2024
  • 全球急性照護症候群檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球急性護理綜合症檢測：總目標市場（TAM）

第6章 市場細分

  • 全球急性照護症候群檢測市場（依疾病類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 呼吸系統疾病
  • 消化系統疾病
  • 泌尿生殖系統疾病
  • 熱帶疾病
  • 其他疾病類型
  • 全球急性照護症候群檢測市場（依樣本類型）：績效與預測，2019-2024 年、2024-2029 年、2034 年
  • 血
  • 尿
  • 生物體液
  • 屎
  • 棉花棒
  • 其他樣本類型
  • 全球急性照護症候群檢測市場：目標、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 細菌
  • 病毒
  • 真菌
  • 寄生蟲
  • 全球急性照護症候群檢測市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 臨床和診斷實驗室
  • 研究和學術機構
  • 其他最終用戶
  • 全球急性照護症候群檢測市場：依呼吸道疾病類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 流感
  • 呼吸道融合細胞病毒（RSV）
  • COVID-19
  • 結核
  • 其他呼吸系統疾病
  • 全球急性照護症候群檢測市場：依胃腸道疾病類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 困難梭狀芽孢桿菌傳染病
  • 諾羅病毒
  • 輪狀病毒
  • 沙門氏菌
  • 其他胃腸道疾病
  • 全球急性照護症候群檢測市場：按泌尿生殖系統疾病類型細分、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 尿道感染（UTI）
  • 性行為感染感染（STI）
  • 陰道感染疾病
  • 其他泌尿生殖系統疾病
  • 全球急性照護症候群檢測市場：按熱帶疾病細分（按類型）、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 瘧疾
  • 登革熱
  • 屈公病
  • 茲卡病毒
  • 其他熱帶疾病
  • 全球急性照護症候群檢測市場：按其他疾病類型細分（按類型）、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 腦膜炎
  • 敗血症
  • 其他新興感染疾病

第7章 區域和國家分析

  • 全球急性照護症候群檢測市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球急性護理綜合症檢測市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 急性護理綜合症檢測市場：競爭格局
  • 急性護理綜合症檢測市場：公司簡介
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Seegene Inc.
  • bioMerieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Werfen
  • DiaSorin SpA
  • Quidel Corporation
  • Luminex Corporation
  • Biocartis NV
  • Microbiologics Inc.
  • QuantuMDx Group Ltd.
  • Curetis GmbH by OpGen Inc.
  • Genetic Signatures Ltd.
  • Applied BioCode Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年急性照護症候群檢測市場：提供新機會的國家
  • 2029 年急性照護症候群檢測市場：細分市場將帶來新機會
  • 2029 年急性護理症候群檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33944u

Acute care syndromic testing is a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. Primarily used in emergency and critical care settings, it enables quicker diagnosis of infectious diseases, leading to faster treatment decisions, improved patient outcomes, and reduced hospital stays.

The main disease types in the acute care syndromic testing market include respiratory diseases, gastrointestinal diseases, genitourinary diseases, tropical diseases, and others. Respiratory diseases affect the lungs, airways, and respiratory tract, causing symptoms such as coughing, shortness of breath, and fever. Various sample types used for testing include blood, urine, biofluids, stool, swabs, and more. The tests target bacteria, viruses, fungi, and parasites and are utilized in hospitals, clinical and diagnostic laboratories, research and academic institutions, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The acute care syndromic testing market research report is one of a series of new reports from The Business Research Company that provides acute care syndromic testing market statistics, including the acute care syndromic testing industry's global market size, regional shares, competitors with a acute care syndromic testing market share, detailed acute care syndromic testing market segments, market trends and opportunities, and any further data you may need to thrive in the acute care syndromic testing industry. This acute care syndromic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The acute care syndromic testing market size has grown rapidly in recent years. It will grow from $4.08 billion in 2024 to $4.59 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increase in awareness of antimicrobial resistance, rise in government funding for infectious disease, increase in investment in healthcare infrastructure, increase focus on syndromic testing, expansion of telemedicine and rise in infectious disease.

The acute care syndromic testing market size is expected to see rapid growth in the next few years. It will grow to $7.39 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to rising prevalence of infectious diseases, growing demand for faster diagnostic solutions, expansion of healthcare services, rising use of multiplex syndromic panels, and growing geriatric population. Major trends in the forecast period include shift toward point-of-care testing, integration of cloud-based platforms, adoption of multiplex panels, development of AI-powered tools, and automation in syndromic testing.

The forecast of 12.7% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply disruptions for multiplex polymerase chain reaction (PCR) cartridges from Singapore and automated sample prep modules from South Korea, slowing infectious disease diagnosis.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of infectious diseases is expected to drive the growth of the acute care syndromic testing market. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can spread through human contact, animals, or the environment. Factors such as population growth, urbanization, global travel, antimicrobial resistance, and climate change are contributing to the rising incidence of these diseases, increasing the demand for effective diagnostic and treatment solutions. Acute care syndromic testing plays a crucial role in identifying pathogens and co-infections through multiplex molecular diagnostics, allowing for targeted treatment decisions. For example, in February 2024, the UK Health Security Agency reported that in week 4 of 2024, the influenza positivity rate rose to 16.6%, up from 14.0% the previous week. Influenza-like illness (ILI) consultations also increased, reaching 9.8 per 100,000 people compared to 7.5 per 100,000 in the prior week, while influenza hospitalizations climbed from 5.12 to 7.63 per 100,000. Consequently, the growing incidence of infectious diseases is fueling the expansion of the acute care syndromic testing market.

Leading companies in the acute care syndromic testing market are leveraging advancements in multiplex real-time polymerase chain reaction (PCR) technology to enhance diagnostic accuracy, enable rapid pathogen detection, streamline laboratory workflows, and reduce turnaround time. Multiplex real-time PCR is an advanced molecular diagnostic method that simultaneously detects and quantifies multiple pathogens or genetic targets in a single reaction, improving efficiency and accuracy in disease diagnosis. In April 2023, QIAGEN N.V., a Netherlands-based biotechnology company, launched the QIAstat-Dx syndromic testing solution in Japan. This system features a SARS-CoV-2 respiratory panel capable of detecting over 20 pathogens from a single sample. Using multiplex real-time PCR technology, it provides rapid results with minimal labor compared to traditional PCR assays. By the end of 2022, over 3,500 QIAstat-Dx systems had been installed worldwide, aiding in the diagnosis of respiratory, gastrointestinal, and meningitis-related conditions. Available in more than 100 countries, this system is improving global access to syndromic testing.

In May 2023, Applied BioCode, a US-based biotechnology company, partnered with Medline Industries to expand the distribution of the BioCode MDx-3000 System. This collaboration aims to enhance access to diagnostic testing for hospitals and reference laboratories across the U.S. Medline Industries LP, a US-based healthcare company specializing in medical supplies and healthcare services, will support the distribution of Applied BioCode's multiplex diagnostic solutions, further advancing syndromic testing capabilities.

Major players in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., and Applied BioCode Inc.

North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in acute care syndromic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acute care syndromic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute care syndromic testing market consists of revenues earned by entities by providing services such as comprehensive pathogen detection, rapid turnaround time, and support for antimicrobial stewardship. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute care syndromic testing market also includes sales of blood collection tubes, or urine containers, PCR and RT-PCR machines, and reader devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Care Syndromic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute care syndromic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute care syndromic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acute care syndromic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease Type: Respiratory Diseases; Gastrointestinal Diseases; Genitourinary Diseases; Tropical Diseases; Other Disease Types
  • 2) By Sample Type: Blood; Urine; Biofluids; Stool; Swabs; Other Sample Types
  • 3) By Target: Bacteria; Viruses; Fungi; Parasites
  • 4) By End User: Hospitals; Clinical And Diagnostic Laboratories; Research And Academic Institutions; Other End Users
  • Subsegments:
  • 1) By Respiratory Diseases: Influenza; Respiratory Syncytial Virus (RSV); COVID-19; Tuberculosis; Other Respiratory Diseases
  • 2) By Gastrointestinal Diseases: Clostridium Difficile Infection; Norovirus; Rotavirus; Salmonella; Other Gastrointestinal Diseases
  • 3) By Genitourinary Diseases: Urinary Tract Infections (UTIs); Sexually Transmitted Infections (STIs); Vaginal Infections; Other Genitourinary Diseases
  • 4) By Tropical Diseases: Malaria; Dengue; Chikungunya; Zika Virus; Other Tropical Diseases
  • 5) By Other Disease Types: Meningitis; Sepsis; Other Emerging Infectious Diseases
  • Companies Mentioned: Siemens Healthineers AG; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company; Seegene Inc.; bioMerieux SA; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Werfen; DiaSorin S.p.A.; Quidel Corporation; Luminex Corporation; Biocartis NV; Microbiologics Inc.; QuantuMDx Group Ltd.; Curetis GmbH by OpGen Inc.; Genetic Signatures Ltd.; Applied BioCode Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Care Syndromic Testing Market Characteristics

3. Acute Care Syndromic Testing Market Trends And Strategies

4. Acute Care Syndromic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Acute Care Syndromic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Acute Care Syndromic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Acute Care Syndromic Testing Market Growth Rate Analysis
  • 5.4. Global Acute Care Syndromic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Acute Care Syndromic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Acute Care Syndromic Testing Total Addressable Market (TAM)

6. Acute Care Syndromic Testing Market Segmentation

  • 6.1. Global Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Respiratory Diseases
  • Gastrointestinal Diseases
  • Genitourinary Diseases
  • Tropical Diseases
  • Other Disease Types
  • 6.2. Global Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Urine
  • Biofluids
  • Stool
  • Swabs
  • Other Sample Type
  • 6.3. Global Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacteria
  • Viruses
  • Fungi
  • Parasites
  • 6.4. Global Acute Care Syndromic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinical And Diagnostic Laboratories
  • Research And Academic Institutions
  • Other End Users
  • 6.5. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Respiratory Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • COVID-19
  • Tuberculosis
  • Other Respiratory Diseases
  • 6.6. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Gastrointestinal Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clostridium Difficile Infection
  • Norovirus
  • Rotavirus
  • Salmonella
  • Other Gastrointestinal Diseases
  • 6.7. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Genitourinary Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urinary Tract Infections (UTIs)
  • Sexually Transmitted Infections (STIs)
  • Vaginal Infections
  • Other Genitourinary Diseases
  • 6.8. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Tropical Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Malaria
  • Dengue
  • Chikungunya
  • Zika Virus
  • Other Tropical Diseases
  • 6.9. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Meningitis
  • Sepsis
  • Other Emerging Infectious Diseases

7. Acute Care Syndromic Testing Market Regional And Country Analysis

  • 7.1. Global Acute Care Syndromic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Acute Care Syndromic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Care Syndromic Testing Market

  • 8.1. Asia-Pacific Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Care Syndromic Testing Market

  • 9.1. China Acute Care Syndromic Testing Market Overview
  • 9.2. China Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Care Syndromic Testing Market

  • 10.1. India Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Care Syndromic Testing Market

  • 11.1. Japan Acute Care Syndromic Testing Market Overview
  • 11.2. Japan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Care Syndromic Testing Market

  • 12.1. Australia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Care Syndromic Testing Market

  • 13.1. Indonesia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Care Syndromic Testing Market

  • 14.1. South Korea Acute Care Syndromic Testing Market Overview
  • 14.2. South Korea Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Care Syndromic Testing Market

  • 15.1. Western Europe Acute Care Syndromic Testing Market Overview
  • 15.2. Western Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Care Syndromic Testing Market

  • 16.1. UK Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Care Syndromic Testing Market

  • 17.1. Germany Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Care Syndromic Testing Market

  • 18.1. France Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Care Syndromic Testing Market

  • 19.1. Italy Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Care Syndromic Testing Market

  • 20.1. Spain Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Care Syndromic Testing Market

  • 21.1. Eastern Europe Acute Care Syndromic Testing Market Overview
  • 21.2. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Care Syndromic Testing Market

  • 22.1. Russia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Care Syndromic Testing Market

  • 23.1. North America Acute Care Syndromic Testing Market Overview
  • 23.2. North America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Care Syndromic Testing Market

  • 24.1. USA Acute Care Syndromic Testing Market Overview
  • 24.2. USA Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Care Syndromic Testing Market

  • 25.1. Canada Acute Care Syndromic Testing Market Overview
  • 25.2. Canada Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Care Syndromic Testing Market

  • 26.1. South America Acute Care Syndromic Testing Market Overview
  • 26.2. South America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Care Syndromic Testing Market

  • 27.1. Brazil Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Care Syndromic Testing Market

  • 28.1. Middle East Acute Care Syndromic Testing Market Overview
  • 28.2. Middle East Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Care Syndromic Testing Market

  • 29.1. Africa Acute Care Syndromic Testing Market Overview
  • 29.2. Africa Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Care Syndromic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Acute Care Syndromic Testing Market Competitive Landscape
  • 30.2. Acute Care Syndromic Testing Market Company Profiles
    • 30.2.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Acute Care Syndromic Testing Market Other Major And Innovative Companies

  • 31.1. Seegene Inc.
  • 31.2. bioMerieux SA
  • 31.3. Sysmex Corporation
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. QIAGEN N.V.
  • 31.6. Werfen
  • 31.7. DiaSorin S.p.A.
  • 31.8. Quidel Corporation
  • 31.9. Luminex Corporation
  • 31.10. Biocartis NV
  • 31.11. Microbiologics Inc.
  • 31.12. QuantuMDx Group Ltd.
  • 31.13. Curetis GmbH by OpGen Inc.
  • 31.14. Genetic Signatures Ltd.
  • 31.15. Applied BioCode Inc.

32. Global Acute Care Syndromic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Care Syndromic Testing Market

34. Recent Developments In The Acute Care Syndromic Testing Market

35. Acute Care Syndromic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Acute Care Syndromic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Acute Care Syndromic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Acute Care Syndromic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer